Fondazione Irccs Policlinico San Matteo Di Pavia
Clinical trials sponsored by Fondazione Irccs Policlinico San Matteo Di Pavia, explained in plain language.
-
New supplement aims to tame blood sugar spikes in prediabetes
Disease control Not yet recruitingThis study tests whether a supplement called GlycoDual can lower blood sugar levels and improve how the body uses insulin in people with prediabetes. About 90 adults with slightly high blood sugar will take either GlycoDual or a placebo for 90 days. Researchers will measure chang…
Phase: NA • Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Disease control
Last updated Apr 23, 2026 12:44 UTC
-
Lung cancer patients to test athletic recovery program
Symptom relief Not yet recruitingThis pilot study will enroll 10 people who had surgery for early-stage non-small cell lung cancer. Participants will follow a 6-month athletic program supervised by a sports scientist. The goal is to see if exercise can improve lung function, fitness, and quality of life after su…
Phase: NA • Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
ICU antibiotic dosing under scrutiny: are patients on ECMO getting enough?
Knowledge-focused Not yet recruitingThis study looks at whether the usual doses of certain strong antibiotics are right for critically ill patients who are on ECMO (heart-lung support) or dialysis. The goal is to make sure the drugs reach levels that kill bacteria without being toxic. About 40 adults in the ICU wit…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 16, 2026 23:48 UTC